Pfizer commits to improve access through a 60 percent price decrease to $1 per dose on drug to treat TB in patients taking second-line HIV/AIDS medications.
Once-daily four-drug combination for “second-line” treatment of HIV/AIDS available from Matrix, a Mylan company, at $475 annually today and at $425 annually in 2010, 28 percent lower than the current lowest-priced alternative.
http://www.blogger.com/post-create.g?blogID=7668402805020631614
Q&A on New Pricing Agreements
http://www.clintonfoundation.org/news/news-media/q-a-on-new-pricing-agreements
NICE PHOTOS Of Bill Clinton during the press release
http://news.yahoo.com/nphotos/slideshow/photo//090806/480/f3e9bb34b0d54a32a24271abce3486be/#photoViewer=/090806/ids_photos_ts/r226852094.jpg
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
http://www.pantsuitpolitics.net/index.php
http://www.HillaryClintonForum.net
http://wwwHillarysVillage.net